Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis

Onno W. Akkerman, Floris Grasmeijer, Wiel C.M. de Lange, Huib A.M. Kerstjens, Gerard de Vries, Mathieu S. Bolhuis, Jan-Willem Alffenaar, Henderik W. Frijlink, Grace Smith, Roger Gajraj, Rina de Zwaan, Paul Hagedoorn, Martin Dedicoat, Dick van Soolingen, Tjip S. van der Werf

Source: Eur Respir J, 51 (3) 1702490; 10.1183/13993003.02490-2017
Journal Issue: March
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Onno W. Akkerman, Floris Grasmeijer, Wiel C.M. de Lange, Huib A.M. Kerstjens, Gerard de Vries, Mathieu S. Bolhuis, Jan-Willem Alffenaar, Henderik W. Frijlink, Grace Smith, Roger Gajraj, Rina de Zwaan, Paul Hagedoorn, Martin Dedicoat, Dick van Soolingen, Tjip S. van der Werf. Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis. Eur Respir J, 51 (3) 1702490; 10.1183/13993003.02490-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical and operational value of the extensively drug-resistant tuberculosis definition
Source: Eur Respir J 2007; 30: 623-626
Year: 2007



Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009



Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases
Source: Eur Respir J, 50 (1) 1700648; 10.1183/13993003.00648-2017
Year: 2017



Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city
Source: Eur Respir J 2013; 41: 901-908
Year: 2013



Clinical outcomes of patients with drug-resistant and extensively drug-resistant tuberculosis in Europe
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008


Treatment options for patients with multidrug-resistant or extensively drug-resistant tuberculosis
Source: Annual Congress 2009 - Priorities in tuberculosis research
Year: 2009


Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis
Source: Eur Respir J 2009; 34: 180-183
Year: 2009



The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis
Source: Eur Respir J, 55 (3) 2000224; 10.1183/13993003.00224-2020
Year: 2020



Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012


Strategies against multidrug-resistant tuberculosis
Source: Eur Respir J 2002; 20: 66S-77S
Year: 2002



Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011


Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012


Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan
Source: ERJ Open Res, 8 (1) 00551-2021; 10.1183/23120541.00551-2021
Year: 2022



ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use
Source: Eur Respir J 2014; 44: 811-815
Year: 2014


Is standardized treatment appropriate for non-XDR multiple drug resistant TB?
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008

The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Source: Eur Respir J 2012; 39: 626-634
Year: 2012



Psychiatric issues during the treatment of the patients with multidrug-resistant tuberculosis
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005


Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005



High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen
Source: Eur Respir J, 52 (6) 1801528; 10.1183/13993003.01528-2018
Year: 2018



Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India
Source: Eur Respir J 2012; 39: 956-962
Year: 2012